Painful Diabetic Peripheral Neuropathy (PDPN): Clinical Trials

7 trials for Painful Diabetic Peripheral Neuropathy (PDPN), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 not yet recruiting, 1 active not recruiting, 1 terminated. 3 Not applicable, 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Not yet recruiting 2, Active not recruiting 1
Phase 22Completed 1, Terminated 1
Phase 32Completed 1, Withdrawn 1

Follow Painful Diabetic Peripheral Neuropathy (PDPN): new trials by email Literature Review of Painful Diabetic Peripheral Neuropathy (PDPN) trials Research Report on Painful Diabetic Peripheral Neuropathy (PDPN)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Acupressure on Symptoms in Elderly Adults With Painful Diabetic Neuropathy
acupressure, placebo acupressure - Painful Diabetic Peripheral Neuropathy (PDPN), Acupressure
Not applicableNot yet recruitingNigde Omer Halisdemir University762026-12-302026-08-25
The Therapeutic Effects of Ceylon Cinnamon Supplementation and a Self-Efficacy Educational Program on Glycemic Control, Lipid Profiles, and Pain in Type 2 Diabetes Mellitus With Painful Diabetic Peripheral Neuropathy
Ceylon Cinnamon (Cinnamomum verum) Supplement, Matching Placebo, Self-Efficacy-Based Educational Program - Type 2 Diabetes Mellitus, Painful Diabetic Peripheral Neuropathy (PDPN)
Not applicableNot yet recruitingJerash Private University9002026-08-012026-08-11
Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy
N0750, Cymbalta®, Lyrica® - Painful Diabetic Peripheral Neuropathy (PDPN)
Phase 3WithdrawnEurofarma Laboratorios S.A.2026-04-012025-12-18
Cryoneurolysis for Painful Diabetic Neuropathy of the Foot
cryoneurolysis, sham cryoneurolysis - Painful Diabetic Peripheral Neuropathy (PDPN)
Not applicableActive not recruitingUniversity of California, San Diego302025-08-252026-07-06
Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy
ASP3662, pregabalin, ASP3662 placebo - Painful Diabetic Peripheral Neuropathy (PDPN)
Phase 2TerminatedAstellas Pharma Global Development, Inc.1152015-05-272019-03-26
A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety
ASP8477, Placebo - Post-Herpetic Neuralgia (PHN), Neuropathic Pain
Phase 2CompletedAstellas Pharma Europe B.V.1322014-02-242017-11-08
A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients
QUTENZA - Painful Diabetic Peripheral Neuropathy (PDPN)
Phase 3CompletedAstellas Pharma Inc4682011-11-012015-10-14

Narrower conditions

Diabetes Mellitus, Type 2 (2)  ·  Neuralgia (2)  ·  Pain (2)  ·  Peripheral Nervous System Diseases (2)  ·  Chronic Pain (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Neuralgia, Postherpetic (1)  ·  Neuritis (1)

Broader conditions

Neurologic Manifestations (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Nervous System Diseases (3)  ·  Neuromuscular Diseases (3)  ·  Endocrine System Diseases (2)  ·  Glucose Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Pain (2)  ·  Autoimmune Diseases (1)  ·  Diabetes Mellitus (1)  ·  Immune System Diseases (1)  ·  Peripheral Nervous System Diseases (1)

Interventions

Pregabalin (2)  ·  ASP3662 (1)  ·  ASP8477 (1)  ·  Acupressure (1)  ·  Capsaicin (1)  ·  Duloxetine Hydrochloride (1)

Sponsors

Astellas Pharma Europe B.V. (1)  ·  Astellas Pharma Global Development, Inc. (1)  ·  Astellas Pharma Inc (1)  ·  Eurofarma Laboratorios S.A. (1)  ·  Jerash Private University (1)  ·  Nigde Omer Halisdemir University (1)  ·  University of California, San Diego (1)

Countries

Czechia (2)  ·  Germany (2)  ·  Poland (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Belgium (1)  ·  Brazil (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Russia (1)  ·  Spain (1)  ·  Ukraine (1)

Results publications

PMID 27919222

NIH funding

2009 (1)